Testosterone monitoring and supplementation in patients with intermediate- or high-risk prostate cancer treated with 6-36 months of androgen deprivation therapy and radiotherapy: a systematic literature review.
- DOI
- 10.1016/j.radonc.2026.111777
- Published
- 2026 Sep 12
- Container
- Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.radonc.2026.111777,
title = {Testosterone monitoring and supplementation in patients with intermediate- or high-risk prostate cancer treated with 6-36 months of androgen deprivation therapy and radiotherapy: a systematic literature review.},
author = {Achard V and Zapatero A and Kishan AU and Blanchard P and Horvath LG and Jereczek-Fossa BA and Tombal B},
year = {2026},
journal = {Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
doi = {10.1016/j.radonc.2026.111777},
url = {https://doi.org/10.1016/j.radonc.2026.111777}
}RIS
TY - JOUR TI - Testosterone monitoring and supplementation in patients with intermediate- or high-risk prostate cancer treated with 6-36 months of androgen deprivation therapy and radiotherapy: a systematic literature review. AU - Achard V AU - Zapatero A AU - Kishan AU AU - Blanchard P AU - Horvath LG AU - Jereczek-Fossa BA AU - Tombal B PY - 2026 JO - Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology DO - 10.1016/j.radonc.2026.111777 UR - https://doi.org/10.1016/j.radonc.2026.111777 ER -
APA
V, A., A, Z., AU, K., P, B., LG, H., BA, J., & B, T. (2026). Testosterone monitoring and supplementation in patients with intermediate- or high-risk prostate cancer treated with 6-36 months of androgen deprivation therapy and radiotherapy: a systematic literature review.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. https://doi.org/10.1016/j.radonc.2026.111777
Source records
- pubmed · retrieved 2026-09-26T12:08:37.433Z